Stock PHARM PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Pharming Group N.V.

Equities

PHARM

NL0010391025

Market Closed - Euronext Amsterdam
Other stock markets
 16:35:00 26/04/2024 BST 		5-day change 1st Jan Change
0.9 EUR +2.16% Intraday chart for Pharming Group N.V. +2.16% -12.71%
04-22 Pharming Group to Buy Back EUR123 Million of Bonds due 2025 MT
04-18 Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds MT

Evolution of the average Target Price on Pharming Group N.V.

Price target over the last 5 years

History of analyst recommendation changes

971fbfb0deb193.DWGr141vAbKgz0YTq0UFKz03DI7wMJVnExRgw8Ga1JU.RSyYhuFYOfPsjn5DmTE3HnBjeuS8SNJffU4xqpDThfluVpul_lhn2_GXBw~e58972680b3864ffb07a6ef495ceaab1

Analyst Recommendations on Pharming Group N.V.

RBC Raises Price Target on Pharming Group to EUR2.10 From EUR1.95, Keeps Outperform Rating MT
Oppenheimer Adjusts Pharming Group Price Target to $40 From $36, Maintains Outperform Rating MT
Oppenheimer Adjusts Pharming Group's Price Target to $36 From $43, Maintains Outperform Rating MT
Van Leeuwenhoeck issues research note on Pharming (PHAR.AS): Turning the Page PU
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.9 EUR
Average target price
2 EUR
Spread / Average Target
+122.22%
High Price Target
2.1 EUR
Spread / Highest target
+133.33%
Low Price Target
1.85 EUR
Spread / Lowest Target
+105.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Pharming Group N.V.

RBC Capital Markets
Oppenheimer

Ratings for Pharming Group N.V.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. Consensus Pharming Group N.V.